Intercell AG wins EUROPEAN BIOTECHNICA AWARD 2006

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

Wien (euro adhoc) - Intercell AG was honoured with the first price in the final
round of the Biotechnica Award 2006 during yesterday’s ceremony at the Biotech
CEO Conference in Zürich. The Biotechnica Award, endowed with 40,000 Euros, is
awarded by the Deutsche Messe AG for the fourth time to European biotech and
life science companies in the fields of biotechnology and related life sciences
with proven success in launching innovative products or services, or in
implementing promising new business concepts.

The jury including experts from science and industry as well as representatives
of the capital markets, has selected three finalists from 16 outstanding
candidates from eight countries in the first round. Alongside scientific
innovation, the jury was judging criteria such as commercial viability, market
relevance, marketing concepts and business models.

The 2nd price was awarded to Genmab S/A, a biotechnology company located in
Denmark, and the 3rd prize was awarded to the German biotech company amaxa GmbH.

Conditions for Applicants:

• Market presence of at least two years
• At least 30 to 350 employees (maximum)
• Annual turnover of up to 50 million euros
• Independent business (maximum 25 percent share of company capital held
by large company, except for venture-capital companies)
• Successful activities on the biotechnology/life sciences markets

For more information, please visit: www.biotechnica.de/award_e

Further inquiry note:
Intercell AG
Mag. Katharina Wieser
Head of Corporate Communications
Tel. +43 1 20620-303
[email protected]

end of announcement euro adhoc 13.10.2006 08:21:21
--------------------------------------------------------------------------------

emitter: Intercell AG
Campus Vienna Biocenter 6
A-1030 Wien
phone: +43 1 20620-0
FAX: +43 1 20620-800
mail: [email protected]
WWW: www.intercell.com
ISIN: AT0000612601
indexes:
stockmarkets: official market: Wiener Börse AG
sector: Biotechnology
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | CNE

print